Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jun;6(11):235.
doi: 10.21037/atm.2018.05.35.

The promise and challenges of chimeric antigen receptor T cells in relapsed B-cell acute lymphoblastic leukemia

Zhi-Chun Ding  1
Affiliations
Editorial

The promise and challenges of chimeric antigen receptor T cells in relapsed B-cell acute lymphoblastic leukemia

Zhi-Chun Ding. Ann Transl Med. 2018 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Comment on

  • Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
    Park JH, Rivière I, Gonen M, Wang X, Sénéchal B, Curran KJ, Sauter C, Wang Y, Santomasso B, Mead E, Roshal M, Maslak P, Davila M, Brentjens RJ, Sadelain M. Park JH, et al. N Engl J Med. 2018 Feb 1;378(5):449-459. doi: 10.1056/NEJMoa1709919. N Engl J Med. 2018. PMID: 29385376 Free PMC article. Clinical Trial.

References

    1. Rosenberg SA, Restifo NP, Yang JC, et al. Adoptive cell transfer:a clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008;8:299-308. 10.1038/nrc2355 - DOI - PMC - PubMed
    1. Rosenberg SA, Packard BS, Aebersold PM, et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med 1988;319:1676-80. 10.1056/NEJM198812223192527 - DOI - PubMed
    1. Lutsiak ME, Semnani RT, De Pascalis R, et al. Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 2005;105:2862-8. 10.1182/blood-2004-06-2410 - DOI - PubMed
    1. Schiavoni G, Sistigu A, Valentini M, et al. Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis. Cancer Res 2011;71:768-78. 10.1158/0008-5472.CAN-10-2788 - DOI - PubMed
    1. Moschella F, Valentini M, Arico E, et al. Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide. Cancer Res 2011;71:3528-39. 10.1158/0008-5472.CAN-10-4523 - DOI - PubMed

LinkOut - more resources